G6PC1 and hepatocellular adenoma: Interestingly, Cho et al. showed that when liver‐specific G6pc‐knockout mice that develop HCA/HCC are treated at the tumor‐developing stage with rAAV‐G6PC, this prevents de novo HCA/HCC development.17